Education
About Us
Working with TipRanks
Follow Us
Koninklijke Philips N.V. (PHG)
NYSE:PHG
PHG Stock Chart & Stats
$29.80
$0.02(0.06%)
At close: 4:00 PM EST
$29.80
$0.02(0.06%)
Day’s Range― - ―
52-Week Range$21.48 - $33.44
Previous CloseN/A
Volume160.28K
Average Volume (3M)1.10M
Market Cap
$25.08B
Enterprise Value$27.24B
Total Cash (Recent Filing)$2.79B
Total Debt (Recent Filing)$8.09B
Price to Earnings (P/E)24.8
Beta0.90
Next Earnings
May 06, 2026EPS Estimate
0.25Next Dividend Ex-DateN/A
Dividend Yield3.3%
Share Statistics
EPS (TTM)0.71
Shares Outstanding962,920,100
10 Day Avg. Volume911,039
30 Day Avg. Volume1,096,728
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)2.02
Price to Sales (P/S)1.24
P/FCF Ratio24.84
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue1.53
Enterprise Value/Gross Profit3.38
Enterprise Value/Ebitda10.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.8
Revenue Forecast (FY)$21.16B
Bulls Say, Bears Say
Bulls Say
Strong Innovation Pipeline And Targeted M&AA steady stream of differentiated product launches (helium-free 3T MRI, AI imaging tools) plus targeted deals like SpectraWAVE expands clinical breadth and improves product mix. Over time this supports higher gross margins, more high-value capital sales and stronger attach rates for services.
Installed-base Recurring Revenue ModelPhilips’ installed-base flywheel—capital equipment sales followed by service, software and consumables—creates recurring revenue and higher margin, sticky customer relationships. This structural mix supports steady aftermarket cash flows and long-term revenue visibility despite cyclical equipment sales.
Proven Productivity Program And Margin RecoverySustained productivity gains materially lowered costs and lifted margins, with management targeting further savings and mid‑teens EBITA by 2028. Structural cost reductions improve margin resilience versus external shocks (tariffs, mix) and provide capacity to invest in R&D and growth initiatives.
Bears Say
Ongoing Respironics Recall And Regulatory ExposureThe long‑tail Respironics remediation and legal actions create persistent cash outflows, heightened regulatory scrutiny and operational constraints. Consent‑decree obligations and investigations can limit speed to market, raise compliance costs, and sustain reputational risk over multiple years.
Material Tariff And Trade HeadwindsSignificant, potentially recurring tariffs materially raise COGS and compress margins for capital equipment. Even with localization and pricing moves, persistent trade measures and policy uncertainty can structurally reduce profitability in affected geographies and product lines unless fully offset.
Volatile Cash Flow And Earnings HistoryHistorically uneven operating cash flow and episodic large items (insurance receipts, settlements) make free‑cash‑flow generation unpredictable. This volatility complicates reinvestment, deleveraging and dividend visibility, and raises execution risk if adverse shocks coincide with weak cash conversion.
Koninklijke Philips News
PHG FAQ
What was Koninklijke Philips N.V.’s price range in the past 12 months?
Koninklijke Philips N.V. lowest stock price was $21.48 and its highest was $33.44 in the past 12 months.
What is Koninklijke Philips N.V.’s market cap?
Koninklijke Philips N.V.’s market cap is $25.08B.
When is Koninklijke Philips N.V.’s upcoming earnings report date?
Koninklijke Philips N.V.’s upcoming earnings report date is May 06, 2026 which is in 43 days.
How were Koninklijke Philips N.V.’s earnings last quarter?
Koninklijke Philips N.V. released its earnings results on Feb 10, 2026. The company reported $0.715 earnings per share for the quarter, beating the consensus estimate of $0.565 by $0.15.
Is Koninklijke Philips N.V. overvalued?
According to Wall Street analysts Koninklijke Philips N.V.’s price is currently Overvalued.
Does Koninklijke Philips N.V. pay dividends?
Koninklijke Philips N.V. pays a Annually dividend of $0.886 which represents an annual dividend yield of 3.3%. See more information on Koninklijke Philips N.V. dividends here
What is Koninklijke Philips N.V.’s EPS estimate?
Koninklijke Philips N.V.’s EPS estimate is 0.25.
How many shares outstanding does Koninklijke Philips N.V. have?
Koninklijke Philips N.V. has 962,920,100 shares outstanding.
What happened to Koninklijke Philips N.V.’s price movement after its last earnings report?
Koninklijke Philips N.V. reported an EPS of $0.715 in its last earnings report, beating expectations of $0.565. Following the earnings report the stock price went up 11.107%.
Which hedge fund is a major shareholder of Koninklijke Philips N.V.?
Currently, no hedge funds are holding shares in PHG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Koninklijke Philips Stock Smart Score
Company Description
Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
PHG Company Deck
PHG Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys a broadly positive operational and financial performance: strong Q4 order intake and sales acceleration, substantial margin expansion, robust Personal Health and Connected Care momentum, significant productivity delivered and an active innovation pipeline. These positives are balanced by tangible near‑term headwinds — notably tariffs (annualized impact in 2026), ongoing Respironics‑related legal and regulatory matters, China tender dynamics, and some D&T margin pressure and Q1 phasing risk. Management has mitigations in place (productivity programs, pricing, localization) and a clear guide for 2026 (3%–4.5% sales growth; 12.5%–13% EBITDA margin), which supports confidence in execution despite the known risks.View all PHG earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
0.49% Mutual Funds
2.46% Other Institutional Investors
96.79% Public Companies and
Individual Investors